Published in Aliment Pharmacol Ther on February 26, 2013
The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther (2015) 2.16
Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am (2014) 1.46
A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study. Am J Gastroenterol (2015) 1.04
Letter: seeking oesophageal eosinophilia among unselected patients--looking for a needle in a haystack? Aliment Pharmacol Ther (2013) 0.75
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology (2007) 9.05
The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology (2006) 3.80
Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol (2010) 3.43
High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol (2008) 3.16
Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol (2005) 3.13
Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc (2006) 2.89
Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol (2008) 2.63
Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol (2007) 2.14
Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology (1978) 2.06
Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut (2006) 1.92
Diagnosis and management of eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 1.90
Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol (2007) 1.76
Eosinophilic oesophagitis in patients presenting with dysphagia--a prospective analysis. Aliment Pharmacol Ther (2008) 1.49
Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol (2009) 1.35
Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology (2011) 1.29
Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol (2012) 1.28
Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther (2010) 1.07
The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study. Aliment Pharmacol Ther (2012) 1.00
Eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease. Dig Dis Sci (2009) 0.91
Eosinophilic infiltration of the esophagus following endoscopic ablation of Barrett's neoplasia. Dis Esophagus (2012) 0.84
Endoscopic ablative therapy for Barrett's esophagus: a potential cause of eosinophilic esophagitis. Dis Esophagus (2011) 0.84
Eosinophilic oesophagitis in adults. Histopathology (2008) 0.80
Prevalence of esophageal eosinophils in patients with Barrett's esophagus. Am J Gastroenterol (2011) 0.80
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res (2001) 6.93
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood (2000) 4.37
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science (2001) 3.39
Prospects for in vivo Raman spectroscopy. Phys Med Biol (2000) 3.32
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med (2000) 3.16
Clinically relevant end points and new drug approvals for myeloma. Leukemia (2007) 2.91
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet (1997) 2.91
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90
The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther (2007) 2.59
The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther (2005) 2.40
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia (2001) 2.30
The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J (1989) 2.25
Can we subtype alcoholism? A latent class analysis of data from relatives of alcoholics in a multicenter family study of alcoholism. Alcohol Clin Exp Res (1996) 2.16
Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth (2002) 2.15
Oncogenic transformation by vrel requires an amino-terminal activation domain. Mol Cell Biol (1990) 2.15
The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut (2007) 2.10
The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications. Oncogene (2001) 2.04
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology (1980) 2.04
Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn (1991) 2.00
Severe hepatitis E infection during pregnancy. J Viral Hepat (1997) 1.96
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma. Oncogene (2006) 1.89
Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther (2009) 1.83
Apolipoprotein E polymorphism and gallstones. Gastroenterology (1996) 1.77
Clinical significance of isolated coronary bridges: benign and frequent condition involving the left anterior descending artery. Am Heart J (1982) 1.66
Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains. Immunology (1981) 1.65
The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther (2006) 1.65
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol (1997) 1.63
Routine coronary angiography prior to elective aortic reconstruction: results of selective myocardial revascularization in patients with peripheral vascular disease. Arch Surg (1979) 1.61
Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis. Gut (1982) 1.60
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood (2001) 1.59
Stress and coping in accident and emergency senior house officers. Emerg Med J (2003) 1.58
Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy (1993) 1.58
Oxidative DNA damage accumulation in gastric carcinogenesis. Gut (1998) 1.57
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood (2001) 1.57
Developmental sequence from disruptive behavior diagnosis to adolescent alcohol dependence. Am J Psychiatry (2001) 1.56
Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol (2001) 1.56
Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci U S A (1990) 1.56
High levels of incorrect use of car seat belts and child restraints in Fife--an important and under-recognised road safety issue. Inj Prev (1997) 1.52
A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology (1992) 1.52
Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood. Dig Liver Dis (2005) 1.51
Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax (2005) 1.50
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther (2006) 1.48
p53 alteration in gastric precancerous lesions. Am J Pathol (1994) 1.45
Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther (2012) 1.45
bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer. Histopathology (1997) 1.43
Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther (2012) 1.40
The utility of the Brief MAST' and the CAGE' in identifying alcohol problems: results from national high-risk and community samples. Arch Fam Med (1997) 1.40
Raman microspectroscopy of human coronary atherosclerosis: biochemical assessment of cellular and extracellular morphologic structures in situ. Cardiovasc Pathol (2001) 1.40
Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther (2007) 1.39
Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology (1986) 1.38
The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol (2001) 1.32
Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res (1996) 1.28
Discovery of a novel, paternally expressed ubiquitin-specific processing protease gene through comparative analysis of an imprinted region of mouse chromosome 7 and human chromosome 19q13.4. Genome Res (2000) 1.27
Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol (2000) 1.24
Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol (2003) 1.23
Loss of FHIT expression in gastric carcinoma. Cancer Res (1998) 1.23
Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology (1990) 1.23
Nonpenetrating trauma to the carotid artery: seven cases and a literature review. J Trauma (1994) 1.23
Novel therapies targeting the myeloma cell and its bone marrow microenvironment. Semin Oncol (2001) 1.22
Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy. Circulation (1998) 1.20
Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine (2002) 1.20
Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res (1996) 1.19
The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin. Ann Oncol (1998) 1.19
Diagnosis of human coronary atherosclerosis by morphology-based Raman spectroscopy. Cardiovasc Pathol (2001) 1.18
Origin of spurious multiple bands in the amplification of microsatellite sequences. Mol Pathol (1999) 1.18
Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology (1998) 1.17
Fez1/lzts1 alterations in gastric carcinoma. Clin Cancer Res (2001) 1.17
Vigorous achalasia: original description requires minor change. J Clin Gastroenterol (2001) 1.16
The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther (2014) 1.14
Large left ventricular metastasis causing left ventricular outflow tract obstruction and haemolysis. Eur J Echocardiogr (2009) 1.13
Changes in hepatitis Be antigen/antibody system in children with chronic hepatitis B virus infection. J Pediatr (1983) 1.13
Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther (2008) 1.12
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey. The Italian Ulcer Study Group "GISU". Dig Liver Dis (2001) 1.11
Squamous cell carcinoma antigen in human liver carcinogenesis. J Clin Pathol (2007) 1.10
Late clinical and arteriographic results in 500 coronary artery reoperations. J Thorac Cardiovasc Surg (1981) 1.10
Validation of administrative data used for the diagnosis of upper gastrointestinal events following nonsteroidal anti-inflammatory drug prescription. Aliment Pharmacol Ther (2006) 1.09
Risk domains associated with an adolescent alcohol dependence diagnosis. Addiction (2001) 1.08
Letter: gastric cancer and pernicious anaemia--often Helicobacter pylori in disguise. Aliment Pharmacol Ther (2013) 1.08
Investigating glutamate receptor-like gene co-expression in Arabidopsis thaliana. Plant Cell Environ (2008) 1.08
Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther (2007) 1.08
Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther (2010) 1.07
Re: The intravaginal slingplasty operation, a minimally invasive technique for cure of urinary incontinence in the female (1) Aust N Z J Obstet Gynaecol (1997) 1.07
Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res (1996) 1.06
Is there autonomic impairment in congestive (dilated) cardiomyopathy? Lancet (1981) 1.06